Financhill
Back

Burning Rock Biotech Ltd. 10K Form

Sell
48

BNR
Burning Rock Biotech Ltd.

Last Price:
$19.31
Seasonality Move:
5.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BNR News And Ratings

See the #1 stock for the next 7 days that we like better than BNR

BNR Financial Statistics

Sales & Book Value

Annual Sales: $71.7M
Cash Flow: $2.2M
Price / Cash Flow: 0
Annual Sales: $7.17
Price / Book: 3.32

Profitability

EPS (TTM): -1.60780
Net Income (TTM): $-16.8M
Gross Margin: $50.4M
Return on Equity: -20.71%
Return on Assets: -13.84%

Burning Rock Biotech Ltd. Earnings Forecast

Key Burning Rock Biotech Ltd. Financial Ratios

  • The Gross Profit Margin over the past 8 years for BNR is 70.26%.
  • The Selling, General & Administrative Expenses for BNR have been equal to 87.73% of Gross Profit Margin.
  • The Research & Development expenses have been 45.03% of Revenue.
  • The Net Earning history of BNR is -67.20% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 2 years.

Burning Rock Biotech Ltd. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: BNR
CUSIP: 12233L
Website: brbiotech.com

Debt

Debt-to-Equity Ratio: 0.06
Current Ratio: 3.14
Quick Ratio: 2.82

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BNR Technical Analysis vs Fundamental Analysis

Sell
48
Burning Rock Biotech Ltd. (BNR) is a Sell

Is Burning Rock Biotech Ltd. a Buy or a Sell?